-
1
-
2
Paving the way for personalized therapies in PDAC: enhanced antitumor activity of decitabine and PARPi treatment in PDAC with a transcriptomic-based KRAS dependency
Veröffentlicht in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
VolltextArtikel